Dick Menzies

12 ta ish

McGill University Health Centre

1. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

   Shama D. Ahuja, David Ashkin, Monika Avendano +70

   Sharh maqolaOAOchiq kirish20129 iqtibos

   ABIABI:AkademIndex/2026.other.027993

2. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/2017.review-article.000004

3. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

   Sharh maqolaOAOchiq kirish20204 iqtibos

   ABIABI:AkademIndex/2026.other.006851

4. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

   Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11

   Sharh maqolaOAOchiq kirish20124 iqtibos

   ABIABI:AkademIndex/2026.other.027990

5. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

   Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies

   Sharh maqolaOAOchiq kirish20174 iqtibos

   ABIABI:AkademIndex/2026.other.027999

6. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

   Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

   Sharh maqolaOAOchiq kirish20144 iqtibos

   ABIABI:AkademIndex/2026.other.034193

7. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

   Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi +16

   Sharh maqolaOAOchiq kirish20122 iqtibos

   ABIABI:AkademIndex/2026.other.027989

8. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

   Keertan Dheda, Tawanda Gumbo, Gary Maartens +39

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.279676

9. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis

   Medea Gegia, Nicholas Winters, Andrea Benedetti +2

   Sharh maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.386596

10. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

    Federica Fregonese, Shama D. Ahuja, Onno W. Akkerman +55

    Sharh maqola20182 iqtibos

    ABIABI:AkademIndex/2026.other.386597

11. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

    ABIABI:AkademIndex/2019.article.000020

12. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

    Elizabeth Harausz, Anthony J. Garcia‐Prats, Stephanie J. Law +47

    Sharh maqolaOAOchiq kirish20181 iqtibos

    ABIABI:AkademIndex/2026.other.135315